Global Prostate Cancer Drugs Market Professional Survey Report 2016
- QYR596781
- 113 Pages
- June 2016
- Pharmaceuticals
Product types including
Targeted Therapies
Chemotherapies
Therapeutic Vaccines
Hormone Therapies
The segment applications including
Hospital use
Clinic use
Others
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
Abbvie?
Astra Zeneca?
Janssen Pharmaceuticals?
Sanofi
Amgen
Bayer
F. Hoffmann-La Roche
GSK
Merck?
Novartis?
Teva Pharmaceuticals
Pfizer?
Ipsen?
Endo Pharmaceuticals?
Astellas
With 15 top producers.
Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Prostate Cancer Drugs
1.1 Definition and Specifications of Prostate Cancer Drugs
1.1.1 Definition of Prostate Cancer Drugs
1.1.2 Specifications of Prostate Cancer Drugs
1.2 Classification of Prostate Cancer Drugs
1.2.1 Targeted Therapies
1.2.2 Chemotherapies
1.2.3 Therapeutic Vaccines
1.2.4 Hormone Therapies
1.3 Applications of Prostate Cancer Drugs
1.3.1 Hospital use
1.3.2 Clinic use
1.3.3 Others
1.4 Industry Chain Structure of Prostate Cancer Drugs
1.5 Industry Overview and Major Regions Status of Prostate Cancer Drugs
1.5.1 Industry Overview of Prostate Cancer Drugs
1.5.2 Global Major Regions Status of Prostate Cancer Drugs
1.6 Industry Policy Analysis of Prostate Cancer Drugs
1.7 Industry News Analysis of Prostate Cancer Drugs
2 Manufacturing Cost Structure Analysis of Prostate Cancer Drugs
2.1 Raw Material Suppliers and Price Analysis of Prostate Cancer Drugs
2.2 Equipment Suppliers and Price Analysis of Prostate Cancer Drugs
2.3 Labor Cost Analysis of Prostate Cancer Drugs
2.4 Other Costs Analysis of Prostate Cancer Drugs
2.5 Manufacturing Cost Structure Analysis of Prostate Cancer Drugs
2.6 Manufacturing Process Analysis of Prostate Cancer Drugs
3 Technical Data and Manufacturing Plants Analysis of Prostate Cancer Drugs
3.1 Capacity and Commercial Production Date of Global Prostate Cancer Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Prostate Cancer Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Prostate Cancer Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Prostate Cancer Drugs Major Manufacturers in 2015
4 Global Prostate Cancer Drugs Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Prostate Cancer Drugs Capacity and Growth Rate Analysis
4.2.2 2015 Prostate Cancer Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Prostate Cancer Drugs Sales and Growth Rate Analysis
4.3.2 2015 Prostate Cancer Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Prostate Cancer Drugs Sales Price
4.4.2 2015 Prostate Cancer Drugs Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Prostate Cancer Drugs Gross Margin
4.5.2 2015 Prostate Cancer Drugs Gross Margin Analysis (Company Segment)
5 Prostate Cancer Drugs Regional Market Analysis
5.1 North America Prostate Cancer Drugs Market Analysis
5.1.1 North America Prostate Cancer Drugs Market Overview
5.1.2 North America 2011-2016E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Prostate Cancer Drugs Sales Price Analysis
5.1.4 North America 2015 Prostate Cancer Drugs Market Share Analysis
5.2 Europe Prostate Cancer Drugs Market Analysis
5.2.1 Europe Prostate Cancer Drugs Market Overview
5.2.2 Europe 2011-2016E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Prostate Cancer Drugs Sales Price Analysis
5.2.4 Europe 2015 Prostate Cancer Drugs Market Share Analysis
5.3 Japan Prostate Cancer Drugs Market Analysis
5.3.1 Japan Prostate Cancer Drugs Market Overview
5.3.2 Japan 2011-2016E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Prostate Cancer Drugs Sales Price Analysis
5.3.4 Japan 2015 Prostate Cancer Drugs Market Share Analysis
5.4 China Prostate Cancer Drugs Market Analysis
5.4.1 China Prostate Cancer Drugs Market Overview
5.4.2 China 2011-2016E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Prostate Cancer Drugs Sales Price Analysis
5.4.4 China 2015 Prostate Cancer Drugs Market Share Analysis
5.5 Southeast Asia Prostate Cancer Drugs Market Analysis
5.5.1 Southeast Asia Prostate Cancer Drugs Market Overview
5.5.2 Southeast Asia 2011-2016E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Prostate Cancer Drugs Sales Price Analysis
5.5.4 Southeast Asia 2015 Prostate Cancer Drugs Market Share Analysis
5.6 India Prostate Cancer Drugs Market Analysis
5.6.1 India Prostate Cancer Drugs Market Overview
5.6.2 India 2011-2016E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Prostate Cancer Drugs Sales Price Analysis
5.6.4 India 2015 Prostate Cancer Drugs Market Share Analysis
6 Global 2011-2016E Prostate Cancer Drugs Segment Market Analysis (by Type)
6.1 Global 2011-2016E Prostate Cancer Drugs Sales by Type
6.2 Different Types Prostate Cancer Drugs Product Interview Price Analysis
6.3 Different Types Prostate Cancer Drugs Product Driving Factors Analysis
6.3.1 Targeted Therapies Prostate Cancer Drugs Growth Driving Factor Analysis
6.3.2 Chemotherapies Prostate Cancer Drugs Growth Driving Factor Analysis
6.3.3 Therapeutic Vaccines Prostate Cancer Drugs Growth Driving Factor Analysis
6.3.4 Hormone Therapies Prostate Cancer Drugs Growth Driving Factor Analysis
7 Global 2011-2016E Prostate Cancer Drugs Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Prostate Cancer Drugs Growth Driving Factor Analysis
7.3.2 Clinic use Prostate Cancer Drugs Growth Driving Factor Analysis
7.3.3 Others Prostate Cancer Drugs Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Prostate Cancer Drugs
8.1 Abbvie?
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Abbvie? 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Abbvie? 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.2 Astra Zeneca?
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Astra Zeneca? 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Astra Zeneca? 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.3 Janssen Pharmaceuticals?
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Janssen Pharmaceuticals? 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Janssen Pharmaceuticals? 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.4 Sanofi
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Sanofi 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Sanofi 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.5 Amgen
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Amgen 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Amgen 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.6 Bayer
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Bayer 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Bayer 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.7 F. Hoffmann-La Roche
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 F. Hoffmann-La Roche 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 F. Hoffmann-La Roche 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.8 GSK
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 GSK 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 GSK 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.9 Merck?
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Merck? 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Merck? 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.10 Novartis?
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Novartis? 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Novartis? 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.11 Teva Pharmaceuticals
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Teva Pharmaceuticals 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Teva Pharmaceuticals 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.12 Pfizer?
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Pfizer? 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Pfizer? 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.13 Ipsen?
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Ipsen? 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Ipsen? 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.14 Endo Pharmaceuticals?
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Endo Pharmaceuticals? 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Endo Pharmaceuticals? 2015 Prostate Cancer Drugs Business Region Distribution Analysis
8.15 Astellas
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Astellas 2015 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Astellas 2015 Prostate Cancer Drugs Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Prostate Cancer Drugs Consumption Forecast
9.2.2 Europe 2016-2021 Prostate Cancer Drugs Consumption Forecast
9.2.3 Japan 2016-2021 Prostate Cancer Drugs Consumption Forecast
9.2.4 China 2016-2021 Prostate Cancer Drugs Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Prostate Cancer Drugs Consumption Forecast
9.2.6 India 2016-2021 Prostate Cancer Drugs Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Prostate Cancer Drugs Marketing Model Analysis
10.1 Prostate Cancer Drugs Regional Marketing Model Analysis
10.2 Prostate Cancer Drugs International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Prostate Cancer Drugs by Regions
10.4 Prostate Cancer Drugs Supply Chain Analysis
11 Consumers Analysis of Prostate Cancer Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Prostate Cancer Drugs
12.1 New Project SWOT Analysis of Prostate Cancer Drugs
12.2 New Project Investment Feasibility Analysis of Prostate Cancer Drugs
13 Conclusion of the Global Prostate Cancer Drugs Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
